BioSpace News Archive

The latest epidemiology and modelling update, shows that we are continuing to make significant progress in bringing COVID-19 disease activity down and raising vaccination coverage up.

The Maryland Tech Council (MTC), Maryland’s largest technology and life sciences trade association, announced today that registration is open for the 2021 Bio Innovation Conference, the first fully integrated event featuring in-person and virtual experiences for the region’s life sciences community.

Nanosonics (ASX: NAN), a leader in infection prevention solutions, today announced the launch of Nanosonics AuditPro™—a new digital product platform offering traceability, reporting and workflow compliance—at the annual Association for Professionals in Infection Control and Epidemiology (APIC) virtual conference, June 28 – 30.

Virta Health, the leader in type 2 diabetes reversal, announced promising results on the ability of its treatment to mitigate COVID-19 severity.

A connective tissue protein known to support the framework of organs also encourages immune responses that fight bacterial infections, while restraining responses that can be deadly in the condition called sepsis, a new study finds.

Zealand has entered an arrangement with Danske Bank A/S to act as exclusive manager under the program.

SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors.

Celcuity Inc., a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, announced that it has commenced an underwritten public offering of shares of its common stock.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), today announced that it has entered into a definitive agreement with certain institutional and accredited investors, including certain directors and officers of the Company, in connection with a private placement of up to $2,000,000 of shares of its common stock and warrants at a purchase price of $0.20 per share and accompanying warrants

A new study from researchers at the Centers for Disease Control and Prevention reveal income-related inequalities in rates of diabetes exist between 2001 and 2018.